PRESS RELEASES
| ELOXATIN™ submitted in the United States and in Europe for the adjuvant treatment of patients with colon cancer |
|
link to Sanofi-Synthelabo's press release of 19th January, 2004
|
| ELOXATIN™ submitted in the United States and in Europe for the adjuvant treatment of patients with colon cancer |
|
link to Sanofi-Synthelabo's press release of 19th January, 2004
|